1. Home
  2. CSPI vs IBIO Comparison

CSPI vs IBIO Comparison

Compare CSPI & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CSP Inc.

CSPI

CSP Inc.

N/A

Current Price

$7.56

Market Cap

74.9M

Sector

Technology

ML Signal

N/A

Logo iBio Inc.

IBIO

iBio Inc.

N/A

Current Price

$1.43

Market Cap

83.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CSPI
IBIO
Founded
1968
2008
Country
United States
United States
Employees
123
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
74.9M
83.5M
IPO Year
1994
2009

Fundamental Metrics

Financial Performance
Metric
CSPI
IBIO
Price
$7.56
$1.43
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$4.75
AVG Volume (30 Days)
10.2K
769.3K
Earning Date
05-08-2026
05-14-2026
Dividend Yield
1.15%
N/A
EPS Growth
75.00
73.08
EPS
N/A
N/A
Revenue
$58,730,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
6.36
N/A
52 Week Low
$7.11
$0.76
52 Week High
$15.00
$3.82

Technical Indicators

Market Signals
Indicator
CSPI
IBIO
Relative Strength Index (RSI) 38.23 46.96
Support Level N/A $1.30
Resistance Level $8.96 $1.54
Average True Range (ATR) 0.44 0.07
MACD -0.07 0.01
Stochastic Oscillator 19.44 45.00

Price Performance

Historical Comparison
CSPI
IBIO

About CSPI CSP Inc.

CSP Inc develops and markets IT integration solutions, security products, managed IT services, cloud services, purpose-built network adapters, and high-performance cluster computer systems. The firm operates in two segments, namely Technology Solutions, where the company focuses on value-added reseller integrated solutions, including third-party hardware, software, and technical computer-related consulting, and High-Performance Products segments, where the company designs, manufactures, and delivers products and services to customers that require specialized cybersecurity services, networking, and signal processing. It generates a majority of its revenue from the Technology Solutions segment. Geographically, the company generates the majority of its revenue from the Americas.

About IBIO iBio Inc.

iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.

Share on Social Networks: